CV Sciences Inc
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements, hemp-based cannabidiol (CBD), and plant based food products in North America. It offers its products under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributor… Read more
CV Sciences Inc (CVSI) - Total Liabilities
Latest total liabilities as of September 2025: $5.46 Million USD
Based on the latest financial reports, CV Sciences Inc (CVSI) has total liabilities worth $5.46 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CV Sciences Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how CV Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CV Sciences Inc Competitors by Total Liabilities
The table below lists competitors of CV Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DILLARDS-A
BE:DL7A
|
Germany | €1.71 Billion |
|
Dien Quang JSC
VN:DQC
|
Vietnam | ₫447.81 Billion |
|
Sunshine Biopharma Inc
NASDAQ:SBFM
|
USA | $7.29 Million |
|
SA Corporate Real Estate Fund Managers Ltd
JSE:SAC
|
South Africa | ZAC8.91 Billion |
|
Peregrine Gold Ltd
AU:PGD
|
Australia | AU$1.08 Million |
|
Silla Sg Co. Ltd
KQ:025870
|
Korea | ₩33.67 Billion |
|
Moatech Co. Ltd
KQ:033200
|
Korea | ₩7.37 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down CV Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.78 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CV Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CV Sciences Inc (2012–2024)
The table below shows the annual total liabilities of CV Sciences Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.13 Million | -2.62% |
| 2023-12-31 | $6.30 Million | -53.40% |
| 2022-12-31 | $13.51 Million | -6.95% |
| 2021-12-31 | $14.52 Million | -25.19% |
| 2020-12-31 | $19.41 Million | -17.53% |
| 2019-12-31 | $23.54 Million | +246.89% |
| 2018-12-31 | $6.79 Million | +7.23% |
| 2017-12-31 | $6.33 Million | +17.55% |
| 2016-12-31 | $5.38 Million | +34.29% |
| 2015-12-31 | $4.01 Million | +502.89% |
| 2014-12-31 | $665.00K | -88.78% |
| 2013-12-31 | $5.92 Million | +592400.00% |
| 2012-12-31 | $1.00K | -- |